Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP33 is a pseudogene derived from the 7SK small nuclear RNA (snRNA) gene family. Pseudogenes are genomic sequences resembling functional genes but generally lack coding or functional potential due to mutations or interruptions in their sequence[4]. The functional 7SK RNA is a ubiquitous, noncoding RNA (approximately 330 nucleotides) involved in the regulation of positive transcription elongation factor b (P-TEFb), thereby controlling RNA polymerase II transcriptional elongation[1][2][3]. 7SK pseudogenes like RN7SKP33 do not produce a functional RNA or protein product, and there is no known biological role, mechanism of action, or disease association for RN7SKP33 itself in current scientific literature[4]. Any discussions of function or therapeutic relevance should focus on the active RN7SK gene, not on its pseudogenes.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 33 (RN7SKP33).